Embryos expressing RhoGEF2UASp.Tag:T7 under the control of Scer\GAL4VP16.nos.UTR show enhanced contractile ring constriction in mid and late cellularization stages, with decreased furrow length.
RhoGEF2UASp.Tag:T7, Scer\GAL4GMR.PU is a suppressor of abnormal cell shape | adult stage phenotype of RhoGAP71EUAS.GFP, Scer\GAL4GMR.PU
RhoGEF2UASp.Tag:T7, Scer\GAL4VP16.nanos.UTR has actomyosin contractile ring | maternal effect | embryonic stage 5 phenotype, suppressible by GrafEY09461, Scer\GAL4VP16.nanos.UTR
RhoGEF2UASp.Tag:T7, Scer\GAL4GMR.PU is a suppressor of eye phenotype of RhoGAP71EUAS.GFP, Scer\GAL4GMR.PU
RhoGEF2UASp.Tag:T7, Scer\GAL4GMR.PU is a suppressor of pigment cell phenotype of RhoGAP71EUAS.GFP, Scer\GAL4GMR.PU
RhoGEF2UASp.Tag:T7, Scer\GAL4VP16.nanos.UTR is a suppressor of actomyosin contractile ring | maternal effect | embryonic stage 5 phenotype of MbsGL01207, Scer\GAL4VP16.nanos.UTR
RhoGEF2UASp.Tag:T7, Scer\GAL4VP16.nanos.UTR is a suppressor of actomyosin contractile ring | maternal effect | embryonic stage 5 phenotype of GrafEY09461, Scer\GAL4VP16.nanos.UTR